$1.38 Earnings Per Share Expected for National Health Investors, Inc. (NHI) This Quarter

Equities analysts expect National Health Investors, Inc. (NYSE:NHI) to report $1.38 earnings per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for National Health Investors’ earnings. The highest EPS estimate is $1.38 and the lowest is $1.37. National Health Investors reported earnings of $1.32 per share in the same quarter last year, which indicates a positive year over year growth rate of 4.5%. The firm is expected to announce its next earnings report on Wednesday, August 8th.

On average, analysts expect that National Health Investors will report full year earnings of $5.50 per share for the current financial year, with EPS estimates ranging from $5.48 to $5.53. For the next year, analysts expect that the company will report earnings of $5.65 per share, with EPS estimates ranging from $5.57 to $5.70. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research firms that cover National Health Investors.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Tuesday, May 8th. The real estate investment trust reported $0.92 earnings per share for the quarter, missing the consensus estimate of $1.34 by ($0.42). The business had revenue of $72.75 million for the quarter, compared to the consensus estimate of $72.04 million. National Health Investors had a net margin of 53.88% and a return on equity of 11.69%. National Health Investors’s revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the business posted $1.25 EPS.

Several brokerages recently weighed in on NHI. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of National Health Investors in a research report on Wednesday, May 16th. Capital One raised shares of National Health Investors from an “equal weight” rating to an “overweight” rating in a research report on Friday, May 11th. KeyCorp cut their price objective on shares of National Health Investors from $70.00 to $60.00 and set a “sell” rating on the stock in a research report on Tuesday, April 17th. BMO Capital Markets set a $70.00 price objective on shares of National Health Investors and gave the company a “hold” rating in a research report on Monday, March 26th. Finally, Mizuho reaffirmed a “hold” rating and set a $70.00 price objective on shares of National Health Investors in a research report on Monday, February 26th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $73.25.

A number of hedge funds have recently made changes to their positions in the business. Allianz Asset Management GmbH grew its holdings in National Health Investors by 7.8% during the first quarter. Allianz Asset Management GmbH now owns 572,100 shares of the real estate investment trust’s stock valued at $38,497,000 after purchasing an additional 41,300 shares during the last quarter. Principal Financial Group Inc. grew its holdings in National Health Investors by 7,076.6% during the first quarter. Principal Financial Group Inc. now owns 506,594 shares of the real estate investment trust’s stock valued at $34,089,000 after purchasing an additional 499,535 shares during the last quarter. WINTON GROUP Ltd acquired a new position in National Health Investors during the first quarter valued at approximately $715,000. Xact Kapitalforvaltning AB grew its holdings in National Health Investors by 37.3% during the first quarter. Xact Kapitalforvaltning AB now owns 5,151 shares of the real estate investment trust’s stock valued at $347,000 after purchasing an additional 1,400 shares during the last quarter. Finally, Legal & General Group Plc grew its holdings in National Health Investors by 10.7% during the first quarter. Legal & General Group Plc now owns 133,324 shares of the real estate investment trust’s stock valued at $8,971,000 after purchasing an additional 12,889 shares during the last quarter. Institutional investors own 70.02% of the company’s stock.

National Health Investors traded up $0.52, hitting $72.26, during midday trading on Friday, according to MarketBeat. 104,523 shares of the company’s stock traded hands, compared to its average volume of 194,555. The firm has a market cap of $2.98 billion, a PE ratio of 13.56, a PEG ratio of 3.72 and a beta of 0.42. The company has a debt-to-equity ratio of 0.88, a quick ratio of 15.21 and a current ratio of 15.21. National Health Investors has a one year low of $62.71 and a one year high of $81.60.

The business also recently declared a quarterly dividend, which will be paid on Friday, August 10th. Shareholders of record on Friday, June 29th will be issued a dividend of $1.00 per share. The ex-dividend date of this dividend is Thursday, June 28th. This represents a $4.00 annualized dividend and a yield of 5.54%. National Health Investors’s dividend payout ratio (DPR) is presently 75.05%.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply